Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-12 Option Award |
2024-12-13 4:23 pm |
N/A 2034-12-12 |
SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director |
8,646 | $0 | 8,646 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-06 4:07 pm |
N/A 2034-06-04 |
Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2024-05-25 Option Award |
2024-05-29 7:20 pm |
N/A 2034-05-25 |
RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director |
55,000 | $0 | 130,000 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-15 4:10 pm |
N/A 2033-12-14 |
SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director |
38,136 | $0 | 38,136 (Direct) |
View |
| 2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director |
55,000 | $0 | 105,000 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 08:06 am |
N/A 2033-06-01 |
Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2022-11-17 Option Award |
2022-11-21 4:30 pm |
N/A 2032-11-16 |
SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director |
46,154 | $0 | 129,747 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2022-06-21 08:32 am |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-09 5:56 pm |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | LAPOINTE ANTHONY GREGG Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director |
55,000 | $0 | 80,000 (Direct) |
View |
| 2021-09-23 Option Award |
2021-09-24 4:21 pm |
N/A 2031-09-22 |
SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director |
29,126 | $0 | 29,126 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:13 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | LAPOINTE ANTHONY GREGG Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-21 8:55 pm |
N/A 2031-05-19 |
RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 4:36 pm |
N/A 2030-09-15 |
SOLIGENIX INC. | SNGX | LAPOINTE ANTHONY GREGG Director |
15,228 | $0 | 15,228 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 11:45 am |
N/A 2030-06-10 |
CATABASIS PHARMACEUTICALS INC | CATB | LAPOINTE ANTHONY GREGG Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-15 8:53 pm |
N/A 2030-05-15 |
RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director |
55,000 | $0 | 55,000 (Direct) |
View |